CLB
Core Laboratories NV
10.40$
-1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 38.6% | 38.1% | 39.0% | 39.1% | 39.2% | 38.4% | 38.7% | 39.5% | 38.4% | 36.8% | 36.5% | 36.5% | |
| 2.8% | 2.6% | 2.5% | 3.0% | 3.6% | 3.2% | 3.7% | 5.2% | 4.3% | 3.9% | 3.9% | 3.9% | |
| 2.8% | 2.6% | 2.5% | 3.0% | 3.6% | 3.2% | 3.7% | 5.2% | 4.3% | 3.9% | 3.9% | 3.9% | |
| 20.5% | 21.0% | 22.0% | 21.9% | 22.0% | 21.6% | 22.1% | 21.3% | 21.1% | 20.7% | 19.6% | 19.8% | |
| 12.7% | 12.2% | 12.0% | 11.7% | 10.9% | 10.1% | 10.0% | 9.9% | 9.8% | 9.3% | 9.8% | 9.9% | |
| 25.8% | – | – | – | 25.7% | 26.0% | 26.3% | 25.4% | 25.7% | 26.3% | – | – | |
| 16.8% | 17.0% | 16.9% | 16.6% | 16.6% | 16.8% | 16.8% | 16.6% | 16.9% | 18.1% | 18.0% | 18.0% | |
| 1.2% | 1.2% | 1.2% | 1.1% | 1.1% | 1.1% | 1.1% | 1.0% | 1.0% | 1.2% | 1.2% | 1.2% | |
| 61.3% | 60.8% | 59.6% | 58.9% | 57.3% | 56.3% | 56.2% | 55.6% | 53.1% | 53.4% | 53.2% | 52.5% | |
| 14.2% | 15.0% | 14.5% | 16.3% | 15.8% | 16.5% | 17.5% | 17.4% | 16.2% | 18.2% | 17.8% | 17.2% | |
| 1.7% | 1.7% | 1.8% | 1.8% | 1.9% | 1.8% | 2.0% | 1.9% | 1.9% | 2.0% | 2.1% | 2.0% | |
| 5.8% | 5.7% | 5.5% | 6.2% | 5.6% | 5.9% | 6.5% | 6.9% | 6.2% | 6.4% | 6.8% | 6.8% | |
| 30.0% | 27.8% | 27.3% | 24.7% | 23.3% | 21.4% | 21.0% | 20.7% | 19.3% | 18.9% | 19.5% | 19.4% | |
| 37.9% | 38.3% | 39.5% | 40.2% | 41.8% | 42.7% | 42.8% | 43.4% | 45.9% | 45.5% | 45.8% | 46.5% | |
| 20.1% | 20.6% | 21.0% | 22.1% | 23.9% | 25.5% | 25.3% | 26.5% | 29.4% | 29.6% | 29.2% | 30.1% | |
| 8.0% | 8.1% | 8.1% | 8.0% | 8.0% | 8.1% | 7.9% | 7.9% | 8.0% | 8.0% | 7.8% | 8.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.